|
Anticuerpos anticardiolipinas IgG factor predictivo riesgo isquemico pacientes cardiovasculares.7
12. OMS. (2004).Centro de de prensa. Revisado 3 de marzo de 2007. Acceso: http://www. who .int/ media centre/ news /releases/ 2004 /pr70/ es/ index .html
13. Beaglehole,R,(2004) Organizacion Panamericana de la salud. Enfermedades Cronicas y Promocion en Salud de la OMS. Ginebra
14. LorenzattI, A., Guzman, A, Cuneo, A. (1999).Nuevos factores de riesgo cardiovascular. Revista Argentina de Cardiología, Volumen 28(1),539-544
15. Wilson, D, Levy, D, Belanger A, Silbershatz, H,,Kannel, W. (1998) Prediction of coronary heart disease using risk factor categories. Circulation. 97:1837
16. Vallabh J, Philip A, Massimo D´ Agostino, R. (2004) “Antibodies Anticardiolpins of risk ischemic stroke na transient ischemic attack”. American Heart Association.Stroke 35:736
17. Khamastha, M, Cuadrado,MJ, Bertoluccini L. (2000) Sindrome de Huges “ Enfermedades Reumaticas Sistemicas, Quito. MSD 126-31
18. Ahmed,B Trifunovic J, Weinehall, L, Hallmans G.(2000) “Antibodies are not na independent risk factor stroke”. American Heart Association, Stroke 31:1289-1293
19. Kelisshad,,R,,Sabet,,B,Khosrovi,A,(2003) “Anticardiolipins Antibodies of adolescxents and age of myocardial infarction in parent. Iran Med Sci Monit 9 (22) CR515-8.
20. Ranzolin A, Bohn A, Caray N y cols (2004) Anticardiolipin Antibodies in Coronary Heart Disease. American Heart Association Inc 40,(3),132-43
21. CYTEL SOFTWARE. 2003. StatXact 6® with Cytel studio. Statistical software for exact nonparametric inference. User manual. Cytel Software. New York. USA. 1398
22. Androniki,B,Arthur,J,,Charles,W.(2000) The thrombogenic factors recurrent coronary event..Universidad of Rochester Medical Center Nueva York
23. Chen, W, Kan, Y, Lan T, Cheng Yy. Chen S, Lin JS. (2006) The increase of blood anticardiolpin antibody depends on the underlyn etiology in cerebral ischemia. Clin Appl Thrombosis Hemost. Junio 12(1)-69-76
|